Pronova Biopharma grows
Recently, Norway's Pronova Biopharma announced the creation of new jobs in Denmark
Pronova Biopharma’s first commercialised omega-3 derived prescription product Omacor is a dietary adjunct for the treatment of elevated triglycerides, which are widely regarded as a risk factor for cardiovascular disease, especially in the overweight. Pronova Biopharma's omega-3 products are produced from fish oil from anchovies and sardines caught in the Pacific and Atlantic Oceans.
The siting of Pronova Biopharma's factory in the same area of the country as Novo Nordisk, Novozymes, and their network of sub-suppliers, has benefited recruitment.
